Kinnate Biopharma
Why Robinhood?
You can watch KNTE and buy or sell other stocks, ETFs, and their options commission-free!About KNTE
Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W.
KNTE Key Statistics
Stock Snapshot
With a market cap of 125.15M, Kinnate Biopharma(KNTE) trades at $2.65. The stock has a price-to-earnings ratio of -1.09.
On 2026-05-13, Kinnate Biopharma(KNTE) stock opened at —, reached a high of —, and a low of —.
The Kinnate Biopharma(KNTE)'s current trading volume is 0, compared to an average daily volume of 367.46K.
In the last year, Kinnate Biopharma(KNTE) shares hit a 52-week high of $6.00 and a 52-week low of $1.04.
In the last year, Kinnate Biopharma(KNTE) shares hit a 52-week high of $6.00 and a 52-week low of $1.04.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.